The effects of maternal year of birth and age on the declining prevalence of neural tube defects after 1972-3 were examined using 403 cases ascertained in a prospective study in the Fylde of Lancashire during 1957-89. Matched case-control data were analysed using conditional logistic regression analysis.
This paper examines the relationship between year of maternal birth, maternal age, and the prevalence of neural tube defects in the Fylde of Lancashire, with particular reference to the decline after 1972-3.
Janerich showed by cohort analysis that the absolute risk of anencephaly was more directly related to the mother's year of birth than to that of the affected child.' This suggested that environmental aetiological factors act early in the mother's life affecting the risk of anencephalic offspring throughout her reproductive period.
In the Fylde during 1957-76 the prevalence of anencephaly fell suddenly and significantly after 1968. 2 The prevalence of spina bifida and cranium bifidum also fell, but to a lesser extent. Subsequently, after the early 1970s, both types of neural tube defect declined.
In England and Wales the decline in prevalence of neural tube defects that began in 1972 was not explicable solely by prenatal diagnosis and termination of pregnancy. 3 In Liverpool the decline from 1974 was more noticeable for anencephaly than spina bifida. 4 In Sheffield a dramatic decline in spina bifida births was partly due to antenatal diagnosis and termination, which was even more successful in reducing anencephaly. 5 We have sought to explain the underlying decline by looking for a maternal age or Births of babies with spina bifida and cranium bifidum also declined after 1973 but the fall was less than for anencephaly. However there were fewer terminations for spina bifida and cranium bifidum so that the underlying decline in prevalence was greater than for anencephaly. ANENCEPHALY Parity (changes in deviance=0-36 on 1 df; p=0 55) followed by maternal year of birth (change in deviance=1-84 on 3 df; p=0-61) were found to be unimportant and were excluded from the logistic regression model. A strong effect of maternal age was observed which could not be excluded from the model (change in deviance= 17-66 on 2 df; p<0-0001). We suggest that administration of mercury was a possible preconditioning event for subsequent spina bifida or cranium bifidum and should be borne in mind when studying their aetiology, although it may now be difficult to obtain additional evidence to support the chronological findings. The lumbar cerebrospinal fluid pressure fell to normal over the first month in 41% of surviving patients in group A, 71% in group B, and 78% in group C, but mortality and morbidity were high in all groups and unaffected by the type of treatment. The overall mortality was 8% for stage II disease and 30% for stage III. Of the survivors of stage III disease 66% were severely mentally impaired (IQ<50), 27% were moderately mentally impaired (IQ 50-85), and 71% had a quadriplegia or a hemiplegia. Of stage II disease survivors 14% were severely mentally impaired, 69% moderately mentally impaired, and 26% had quadriplegia or hemiplegia.
The severity of disease at presentation is the most important factor determining outcome. This work has not shown that treatment of the hydrocephalus does anything to help these children. Intrathecal hyaluronidase did not seem to have harmful effects but acetazolamide and frusemide produced dehydration in three patients possibly associated with sagittal sinus thrombosis in one. Of the 24 children who had a ventriculoperitoneal shunt procedure five developed shunt dysfunction. Four of these had an infected shunt and they all died. These authors give no compelling reason for treating communicating hydrocephalus in tuberculous meningitis, although they advocate treatment with acetazolamide and frusemide. For non-communicating hydrocephalus they recommend early shunt surgery but the data they present do not permit an evaluation of that recommendation. ARCHIVIST 
